Gastrointestinal Cancer

On March 21, at 9 PM EST, the #CureConnect tweetchat will be focusing on screening and prevention. Sharyn Worrall, Patient Education Manager for FightCRC will be comoderating on this topic, which is especially important for colorectal cancer.

Patients new to ostomy often rely on nurses to help them select the appropriate supplies and assist with application.

A recent study has found that the rates of colorectal cancer are rising in young adults.

At the University of Virginia (UVA) Health System, the enhanced recovery after surgery (ERAS) program in colorectal cancer has improved outcomes of patients after procedures and reduced hospital costs.

According to new analysis, patients with metastatic colorectal cancer (mCRC) who engaged in daily exercise demonstrated improved outcomes.

A recent study links aspirin use to a reduced risk of pancreatic cancer.

A daily aspirin regimen could lower your risk of pancreatic cancer.

Patients with a recent diagnosis of diabetes mellitus (DM) and have undergone a surgical resection for pancreatic ductal adenocarcinoma may have poorer survival outcomes.

The incidence of hepatocellular carcinoma (HCC) in patients with hepatitis B is still on the rise, making screening and surveillance in this population all the more important.

Regorafenib was found to improve overall survival by nearly 3 months for patients with previously treated hepatocellular carcinoma.

With the mortality rate for liver cancer rising faster than the mortality rate for any other cancer, it is important that oncology nurses are aware of risk factors, screening, and treatments so they can pass information on to their patients.

Researchers analyzed Bing.com search logs to identify those recently diagnosed with pancreatic cancer. Through symptom patterns expressed as searches, they were able to identify 5% to 15% of pancreatic cancer cases.

Colorectal cancer mortality rates have been on the decline in California for both men and women since the mid-1990s, but for one group—Hispanic men—rates have remained essentially unchanged, and a new study suggests that lower rates of screening may be the chief driver of this disparity.

A large, population-based study found that obesity more prevalent in patients with a history of cancer than in the general population, suggesting an important area of focus and a need for improved weight management and control programs targeted at survivors’ specific needs.

Dave Dubin, founder of AliveAndKickn, discusses the importance of healthcare professionals knowing when to test for Lynch syndrome.

Mutations in BRCA1 and BRCA2, most commonly linked with breast and ovarian cancers, are now gaining wider recognition for being associated with pancreatic cancer as well.

For uninsured patients who are at a high risk for colorectal cancer (CRC), performing free screening colonoscopies can identify cancer at an earlier stage and appears to be cost neutral from a hospital system perspective.

Kyung Chu, RN, NYU Langone Perlmutter Cancer Center, discusses treating patients with different subtypes of KRAS mutation.

Barry Berger, MD, Exact Sciences Corporation, discusses Cologuard, an at-home screening for colorectal cancer.

Much work needs to be done to increase Lynch syndrome screening rates and better understand the factors that are associated with low testing rates.

A study published by researchers at the Dana Farber-Cancer Institute recently discovered that financial status plays a large role in the level of symptom burden and quality of life for patients newly diagnosed with lung or colorectal cancer.

Is there a treatment-related survival benefit for older patients with metastatic colorectal cancer?